期刊
VACCINE
卷 33, 期 31, 页码 3650-3658出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2015.05.104
关键词
Oral vaccine; Vaccine cost; Transgenic plant; Transient expression; Transplastomic plant; Edible crop; E antigen; Virus like particles
资金
- CONACTINexico [CB-2008-01, 102109, CB-2010-01, 151818]
- FAI/UASLP/2015
Chikungunya virus is an emerging pathogen initially found in East Africa and currently spread into the Indian Ocean Islands, many regions of South East Asia, and in the Americas. No licensed vaccines against this eminent pathogen are available and thus intensive research in this field is a priority. This review presents the current scenario on the developments of Chikungunya virus vaccines and identifies the use of genetic engineered plants to develop attractive vaccines. The possible avenues to develop plant-made vaccines with distinct antigenic designs and expression modalities are identified and discussed considering current trends in the field. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据